MicroRNA-146a governs fibroblast activation and joint pathology in arthritis

Bluml, 2014, Mechanisms of tissue damage in arthritis, Semin. Immunopathol., 36, 531, 10.1007/s00281-014-0442-8 McInnes, 2007, Cytokines in the pathogenesis of rheumatoid arthritis, Nat. Rev. Immunol., 7, 429, 10.1038/nri2094 Scott, 2003, Joint damage and disability in rheumatoid arthritis: an updated systematic review, Clin. Exp. Rheumatol., 21, S20 Tak, 1999, Current perspectives on synovitis, Arthritis Res., 1, 11, 10.1186/ar4 McInnes, 2011, The pathogenesis of rheumatoid arthritis, N. Engl. J. Med., 365, 2205, 10.1056/NEJMra1004965 Redlich, 2012, Inflammatory bone loss: pathogenesis and therapeutic intervention, Nat. Rev. Drug Discov., 11, 234, 10.1038/nrd3669 Scheinecker, 2008, Cytokines as therapeutic targets: advances and limitations, Immunity, 28, 440, 10.1016/j.immuni.2008.03.005 Redlich, 2003, Rheumatoid arthritis therapy after tumor necrosis factor and interleukin-1 blockade, Arthritis Rheum., 48, 3308, 10.1002/art.11358 Bartel, 2004, Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs, Nat. Rev. Genet., 5, 396, 10.1038/nrg1328 Lodish, 2008, Micromanagement of the immune system by microRNAs, Nat. Rev. Immunol., 8, 120, 10.1038/nri2252 Carthew, 2009, Origins and Mechanisms of miRNAs and siRNAs, Cell., 136, 642, 10.1016/j.cell.2009.01.035 Wang, 2009, Cell cycle regulation by MicroRNAs in embryonic stem cells, Cancer Res., 69, 4093, 10.1158/0008-5472.CAN-09-0309 Winter, 2009, Many roads to maturity: microRNA biogenesis pathways and their regulation, Nat. Cell Biol., 11, 228, 10.1038/ncb0309-228 Rodriguez, 2007, Requirement of bic/microRNA-155 for normal immune function, Science, 316, 608, 10.1126/science.1139253 Thai, 2007, Regulation of the germinal center response by microRNA-155, Science, 316, 604, 10.1126/science.1141229 Boldin, 2011, miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice, J. Exp. Med., 208, 1189, 10.1084/jem.20101823 O'Connell, 2010, MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development, Immunity, 33, 607, 10.1016/j.immuni.2010.09.009 Bluml, 2011, Essential role of microRNA-155 in the pathogenesis of autoimmune arthritis in mice, Arthritis Rheum., 63, 1281, 10.1002/art.30281 Kurowska-Stolarska, 2011, MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis, Proc. Natl. Acad. Sci. U. S. A., 108, 11193, 10.1073/pnas.1019536108 Chatzikyriakidou, 2012, miRNAs and related polymorphisms in rheumatoid arthritis susceptibility, Autoimmun. Rev., 11, 636, 10.1016/j.autrev.2011.11.004 Taganov, 2006, NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses, Proc. Natl. Acad. Sci. U. S. A., 103, 12481, 10.1073/pnas.0605298103 Lu, 2010, Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses, Cell., 142, 914, 10.1016/j.cell.2010.08.012 Etzrodt, 2012, Regulation of monocyte functional heterogeneity by miR-146a and Relb, Cell Rep., 1, 317, 10.1016/j.celrep.2012.02.009 Yang, 2012, miR-146a controls the resolution of T cell responses in mice, J. Exp. Med., 209, 1655, 10.1084/jem.20112218 Zhao, 2013, MicroRNA-146a acts as a guardian of the quality and longevity of hematopoietic stem cells in mice, eLife, 2, e00537, 10.7554/eLife.00537 Abou-Zeid, 2011, MicroRNA 146a expression in rheumatoid arthritis: association with tumor necrosis factor-alpha and disease activity, Genet. Test. Mol. Biomark., 15, 807, 10.1089/gtmb.2011.0026 Filkova, 2014, Association of circulating miR-223 and miR-16 with disease activity in patients with early rheumatoid arthritis, Ann. Rheum. Dis., 73, 1898, 10.1136/annrheumdis-2012-202815 Nakasa, 2008, Expression of microRNA-146 in rheumatoid arthritis synovial tissue, Arthritis Rheum., 58, 1284, 10.1002/art.23429 Pauley, 2008, Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients, Arthritis Res. Ther., 10, R101, 10.1186/ar2493 Stanczyk, 2008, Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis, Arthritis Rheum., 58, 1001, 10.1002/art.23386 Nakasa, 2011, The inhibitory effect of microRNA-146a expression on bone destruction in collagen-induced arthritis, Arthritis Rheum., 63, 1582, 10.1002/art.30321 Lochhead, 2014, MicroRNA-146a provides feedback regulation of lyme arthritis but not carditis during infection with Borrelia burgdorferi, PLoS Pathog., 10, e1004212, 10.1371/journal.ppat.1004212 Keffer, 1991, Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis, EMBO J., 10, 4025, 10.1002/j.1460-2075.1991.tb04978.x Bluml, 2010, Antiinflammatory effects of tumor necrosis factor on hematopoietic cells in a murine model of erosive arthritis, Arthritis Rheum., 62, 1608, 10.1002/art.27399 Bluml, 2015, Loss of phosphatase and tensin homolog (PTEN) in myeloid cells controls inflammatory bone destruction by regulating the osteoclastogenic potential of myeloid cells, Ann. Rheum. Dis., 74, 227, 10.1136/annrheumdis-2013-203486 Rosner, 2010, Efficient siRNA-mediated prolonged gene silencing in human amniotic fluid stem cells, Nat. Protoc., 5, 1081, 10.1038/nprot.2010.74 Kiener, 2010, Synovial fibroblasts self-direct multicellular lining architecture and synthetic function in three-dimensional organ culture, Arthritis Rheum., 62, 742, 10.1002/art.27285 Starczynowski, 2011, TRAF6 is an amplified oncogene bridging the RAS and NF-kappaB pathways in human lung cancer, J. Clin. Investig., 121, 4095, 10.1172/JCI58818 Assmann, 2016, Metabolic regulation of immune responses: therapeutic opportunities, J. Clin. Investig., 126, 2031, 10.1172/JCI83005 Danks, 2016, RANKL expressed on synovial fibroblasts is primarily responsible for bone erosions during joint inflammation, Ann. Rheum. Dis., 75, 1187, 10.1136/annrheumdis-2014-207137 Walsh, 2008, TRAF6 autoubiquitination-independent activation of the NFkappaB and MAPK pathways in response to IL-1 and RANKL, PLoS One, 3, e4064, 10.1371/journal.pone.0004064 Yamada, 2001, IL-1 induced chemokine production through the association of Syk with TNF receptor-associated factor-6 in nasal fibroblast lines, J. Immunol., 167, 283, 10.4049/jimmunol.167.1.283 Lomaga, 1999, TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling, Genes & Dev., 13, 1015, 10.1101/gad.13.8.1015 Wei, 2005, IL-1 mediates TNF-induced osteoclastogenesis, J. Clin. Investig., 115, 282, 10.1172/JCI200523394